Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade
在多发性骨髓瘤中,CD39和CD73介导的ATP转化为腺苷的过程可以与腺苷受体A2A阻断剂联合使用,从而达到治疗目的。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2020-000610
Yang, Rui; Elsaadi, Samah; Misund, Kristine; Abdollahi, Pegah; Vandsemb, Esten Nymoen; Moen, Siv Helen; Kusnierczyk, Anna; Slupphaug, Geir; Standal, Therese; Waage, Anders; Slørdahl, Tobias S; Rø, Torstein Baade; Rustad, Even; Sundan, Anders; Hay, Carl; Cooper, Zachary; Schuller, Alwin G; Woessner, Richard; Borodovsky, Alexandra; Menu, Eline; Børset, Magne; Sponaas, Anne Marit
CD7
多发性骨髓瘤
CD39
信号转导
CD73
CD3
骨髓瘤